StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)

Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%

Johnson & Johnson total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Johnson & Johnson's total debt was $44.65B at Sep 27, 2026. For fiscal 2025 it was $47.94B, up 30.8% from the year before. Over ten years it grew 9.2% a year on average. The highest annual figure on record is $47.94B in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 28, 2025$47.94B+30.8%
FY2024Dec 29, 2024$36.65B+24.7%
FY2023Dec 31, 2023$29.38B-26.0%
FY2022Jan 1, 2023$39.69B+17.5%
FY2021Jan 2, 2022$33.79B-4.1%
FY2020Jan 3, 2021$35.24B+27.2%
FY2019Dec 29, 2019$27.69B-9.2%
FY2018Dec 30, 2018$30.48B-11.8%
FY2017Dec 31, 2017$34.58B+27.4%
FY2016Jan 1, 2017$27.14B+36.7%
FY2015Jan 3, 2016$19.86B+6.1%
FY2014Dec 28, 2014$18.72B+2.7%
FY2013Dec 29, 2013$18.23B+12.6%
FY2012Dec 30, 2012$16.19B-17.7%
FY2011Jan 1, 2012$19.67B+17.4%
FY2010Jan 2, 2011$16.76B+15.0%
FY2009Jan 3, 2010$14.58B+23.0%
FY2008Dec 28, 2008$11.85B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$44.65B-2.5%
Q2 FY2026Jun 28, 2026$49.04B-3.4%
Q1 FY2026Mar 29, 2026$54.99B+5.2%
Q4 FY2025Dec 28, 2025$47.94B+30.8%
Q3 FY2025Sep 28, 2025$45.80B+28.1%
Q2 FY2025Jun 29, 2025$50.76B+22.3%
Q1 FY2025Mar 30, 2025$52.25B+55.4%
Q4 FY2024Dec 29, 2024$36.65B+24.7%
Q3 FY2024Sep 29, 2024$35.75B+19.5%
Q2 FY2024Jun 30, 2024$41.49B-9.0%
Q1 FY2024Mar 31, 2024$33.63B-36.4%
Q4 FY2023Dec 31, 2023$29.38B-26.0%
Q3 FY2023Oct 1, 2023$29.92B-6.6%
Q2 FY2023Jul 2, 2023$45.60B+39.9%
Q1 FY2023Apr 2, 2023$52.91B+59.6%
Q4 FY2022Jan 1, 2023$39.69B+17.5%
Q3 FY2022Oct 2, 2022$32.03B-5.6%
Q2 FY2022Jul 3, 2022$32.60B-2.6%
Q1 FY2022Apr 3, 2022$33.15B-1.4%
Q4 FY2021Jan 2, 2022$33.79B-4.1%
Q3 FY2021Oct 3, 2021$33.93B-10.1%
Q2 FY2021Jul 4, 2021$33.48B+10.2%
Q1 FY2021Apr 4, 2021$33.61B+21.9%
Q4 FY2020Jan 3, 2021$35.24B+27.2%
Q3 FY2020Sep 27, 2020$37.76B+29.2%
Q2 FY2020Jun 28, 2020$30.39B+3.3%
Q1 FY2020Mar 29, 2020$27.58B-6.1%
Q4 FY2019Dec 29, 2019$27.69B-9.2%
Q3 FY2019Sep 29, 2019$29.22B-6.5%
Q2 FY2019Jun 30, 2019$29.42B-8.3%
Q1 FY2019Mar 31, 2019$29.37B-9.7%
Q4 FY2018Dec 30, 2018$30.48B-11.8%
Q3 FY2018Sep 30, 2018$31.25B-11.1%
Q2 FY2018Jul 1, 2018$32.08B-7.2%
Q1 FY2018Apr 1, 2018$32.53B+0.5%
Q4 FY2017Dec 31, 2017$34.58B+27.4%
Q3 FY2017Oct 1, 2017$35.17B–
Q2 FY2017Jul 2, 2017$34.57B–
Q1 FY2017Apr 2, 2017$32.37B–
Q4 FY2016Jan 1, 2017$27.14B–

More Johnson & Johnson figures

See a number that looks wrong?